Maartje E. Van Kats - Publications

Receptor Discordance During the Treatment Course of Patients With Metastatic Breast Cancer: Results From the SONABRE Registry.

Journal: Clinical breast cancer

Published: April 24, 2025

The effect of neoadjuvant chemotherapy on ductal carcinoma in situ in triple-negative breast cancer patients: A nationwide analysis.

Journal: Breast (Edinburgh, Scotland)

Published: December 30, 2024

Model-Informed Development of a Cost-Saving Dosing Regimen for Sacituzumab Govitecan.

Journal: Targeted oncology

Published: May 20, 2024

Surgical outcomes and prognosis of HER2+ invasive breast cancer patients with a DCIS component treated with breast-conserving surgery after neoadjuvant systemic therapy.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: March 15, 2024

Case series of metastatic breast cancer patients with visceral crisis treated with CDK4/6 inhibitors.

Journal: Journal of chemotherapy (Florence, Italy)

Published: November 10, 2023

Trastuzumab Resistance in Patients With HER2-Positive Advanced Breast Cancer: Results From the SONABRE Registry.

Journal: Clinical breast cancer

Published: April 03, 2023

Pathologic complete response of ductal carcinoma in situ to neoadjuvant systemic therapy in HER2-positive invasive breast cancer patients: a nationwide analysis.

Journal: Breast cancer research and treatment

Published: March 29, 2023

Real-world time trends in overall survival, treatments and patient characteristics in HR+/HER2- metastatic breast cancer: an observational study of the SONABRE Registry.

Journal: The Lancet regional health. Europe

Published: October 11, 2022